ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.22
-0.93%
US Tech 100
18,488.00
-0.25%
S&P 500
5,346.99
-0.11%
US Dollar vs CAD
1.37725
-0.03%
Bitcoin
69,378.50
0.07%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. USOTC
  6. Pathfinder Cell Therapy Inc (CE) (PFND)

  7. Pathfinder Cell Therapy Inc (CE) (PFND) News

PFND

Pathfinder Cell Therapy (CE) (PFND)

Pathfinder Cell Therapy Inc (CE)
Date:
Sort by:
 Showing the most relevant articles for your search:USOTC:PFND
DateTimeSourceHeadlineSymbolCompany
04/05/20165:01AMEdgar (US Regulatory)Notice of Effectiveness (effect)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
03/30/20163:16PMEdgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
03/29/20164:26PMEdgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
03/29/20162:26PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
03/29/201612:40PMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
03/29/201612:37PMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
03/29/201612:37PMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
03/29/201612:35PMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
03/29/201612:32PMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
03/29/20165:01AMEdgar (US Regulatory)Notice of Effectiveness (effect)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
03/29/20165:01AMEdgar (US Regulatory)Notice of Effectiveness (effect)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
03/16/20169:59AMEdgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
03/16/20169:56AMEdgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
12/04/20159:04AMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
11/13/201510:23AMEdgar (US Regulatory)Quarterly Report (10-q)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
11/04/20159:21AMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
10/07/20158:19AMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
09/01/20151:12PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
08/18/201511:20AMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
08/13/201511:14AMEdgar (US Regulatory)Quarterly Report (10-q)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
07/20/201511:56AMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
06/09/20152:24PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
05/15/20157:09AMEdgar (US Regulatory)Quarterly Report (10-q)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
03/31/201511:19AMEdgar (US Regulatory)Annual Report (10-k)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
03/06/20151:55PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
02/03/20153:11PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
12/31/20149:25AMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
12/02/20147:56AMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
11/14/201412:11PMEdgar (US Regulatory)Quarterly Report (10-q)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
10/28/201410:33AMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
 Showing the most relevant articles for your search:USOTC:PFND

Your Recent History

USOTC
GVSI
Good Vibrations Shoes (PK)
USOTC
GNCP
GNCC Capital (CE)
USOTC
SAPX
Seven Arts Entertainment (PK)
NASDAQ
RVNC
Revance Therapeutics
USOTC
ELTP
Elite Pharmaceuticals (QB)
USOTC
VPLM
Voip Pal Com (QB)
USOTC
BIEL
Bioelectronics (PK)
NASDAQ
NB
NioCorp Developments
USOTC
AHRO
Authentic (CE)
USOTC
PHIL
PHI (PK)
USOTC
UBQU
Ubiquitech Software (PK)
NASDAQ
COOP
Mr Cooper
USOTC
AXXA
Exxe (PK)
USOTC
SMCE
SMC Entertainment (PK)
USOTC
RONN
Ronn Motor (PK)
USOTC
NWBO
Northwest Biotherapeutics (QB)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved